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Title: The interaction of caseload and usage in determining outcomes of unicompartmental 1 
knee arthroplasty: A meta-analysis 2 
Abstract     3 
Background: Outcomes following UKA are variable and influenced by surgical caseload 4 
(UKA/year) and usage (percentage of primary knee arthroplasty that are UKA), which relates to 5 
indications. This meta-analysis assesses the relative importance of these factors. 6 
Methods: MEDLINE (Ovid), Embase (Ovid) and the Web of Science (ISI) were searched for 7 
consecutive series of minimally invasive cemented Phase 3 Oxford medial UKA. The primary 8 
outcome measure was revision-rate/100 observed component years (%pa). Series were divided 9 
into groups according to caseload and usage. 10 
Results: 46studies, including 12,520 knees, were identified. The annual revision-rate varied 11 
from 0%pa to 4.35%pa, mean 1.21%pa (95%CI 0.97-1.47).  In series with mean follow-up of 12 
ten-years or more the revision-rate was 0.63%pa (95%CI 0.46-0.83), which equates to a ten-13 
year survival of 94% (95%CI 92%-95%). Aseptic loosening, lateral arthritis, bearing dislocation, 14 
and unexplained pain were the predominant failure mechanisms with revision for patello-femoral 15 
problems and polyethylene wear exceedingly rare (<0.1%).  16 
Both increasing caseload (p=0.02) and usage (p<0.001) were associated with decreasing 17 
revision-rate. The lowest revision-rates were achieved with a caseload >24 UKA/year (0.88%pa, 18 
95%CI 0.63-1.61) and usage >30% (0.69%pa, 95%CI 0.50-0.90). Usage was more important 19 
than caseload: with high-usage (≥20%) the revision-rate was low, whether the caseload was 20 
high (>12UKA/year) or low (≤12UKA/year), (0.94%pa (95%CI 0.69-1.23) and 0.85%pa (95%CI 21 
0.65-1.08) respectively); whereas with low-usage (<20%) the revision-rate was high, whether 22 
the caseload was high or low (1.58%pa, 95%CI 0.57- 3.05 and 1.76%pa, 95%CI 1.21-2.41). 23 
Conclusion: To achieve optimum results with mobile-bearing UKA surgeons, whether high or 24 
low-caseload, should adhere to the recommended indications such that ≥20%, or ideally >30% 25 
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of their knee replacements are UKA. If they do this then they can expect to achieve results 26 
similar to those of the long-term series, which all had high-usage (>20%) and an average ten-27 
year survival of 94%. 28 
Level of Evidence: Level 2 29 
Keywords: Unicompartmental knee arthroplasty, implant survival, meta-analysis  30 
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Introduction  31 
In appropriate patients UKA has significant benefits over TKA including faster recovery, better 32 
patient reported outcome measures (PROMS) and lower morbidity and mortality, however, it 33 
has been reported to be associated with a higher incidence of failure[1]. The causes of failure 34 
are multi-factorial but involve a complex interaction of patient, implant and surgeon factors as 35 
well as differing thresholds for revision compared to TKA[2]. 36 
Surgeon factors associated with outcome include technical skills associated with the procedure 37 
itself as well as non-technical skills associated with decision-making around patient selection. 38 
Technical skills have been hypothesised to improve as surgical volume increases and in TKA it 39 
has been demonstrated that high-volume surgeons have lower procedure times, transfusion 40 
rates and inpatient stays which culminate in better PROMS[3]. Similar findings have been 41 
reported in UKA, albeit more marked than TKA, with a fourfold difference in revision rates seen 42 
between the lowest and highest-volume surgeons using joint registry data suggesting that UKA 43 
may be more sensitive to technical errors [4].  44 
Non-technical skills associated with decision-making around patient selection are related to 45 
surgical indications. In severe osteoarthritis which fails non-operative treatments surgeons can 46 
choose between UKA and TKA. This decision relates to an individual surgeon’s indications, 47 
which is reflected by the relative proportions of a surgeon’s primary knee practice that receive 48 
UKA relative to TKA. In UKA it has been demonstrated that, within certain limits, surgeons who 49 
use broad indications, as assessed by a high proportion of patients receiving UKA, have lower 50 
revision rates compared to surgeons who use narrow indications. The indications for mobile-51 
bearing UKA are satisfied in about 50% of knees needing replacement. With mobile-bearing 52 
UKA acceptable revision rates tend to be achieved by surgeons who use UKA for 20% or more 53 
of their knee replacements and optimal results are achieved in those who use UKA for about 54 
50% of their knee replacements [5]. 55 
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It has been reported that optimum outcomes following UKA are achieved either when a surgeon 56 
operates on high-volume of cases (high-caseload) or has a practice where a high-proportion of 57 
primary knee arthroplasties are UKA (high-usage)[4, 5]. The relative importance of each of 58 
these factors on implant survival following UKA has not been explored. At present it is unclear 59 
whether good outcomes can be achieved when a surgeon has a high-caseload but uses narrow 60 
indications such that they have low-usage, or vice versa where a surgeon has a low-caseload 61 
but implants UKA in high proportion of cases (high-usage). This is relevant with regards to the 62 
provision of UKA as a surgeon cannot change the volume of their practice but can change 63 
percentage of knees which can be UKA. 64 
The objective of this meta-analysis is review the results of the Phase 3 cemented Oxford UKA, 65 
to determine the importance of caseload and usage of UKA on implant survival and mechanism 66 
of failure and to assess the interplay between these two factors. 67 
  68 
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Materials and Methods 69 
Search strategy and criteria 70 
MEDLINE (Ovid), Embase (Ovid) and the Web of Science (ISI) were searched to identify 71 
studies reporting the outcomes of the cemented Phase 3 Oxford medial UKA (Zimmer Biomet, 72 
Warsaw, Indiana) implanted through a minimally invasive approach between 1998, the year the 73 
Phase 3 was introduced, and 17 March 2016. Appendix 1. In addition reference lists of included 74 
publications, published reviews, conference abstracts and experts in the field were contacted to 75 
identify additional reports. 76 
Studies were excluded if they did not report the outcomes of a consecutive series of knees or 77 
did not present implant survival data. Registry studies were excluded due to the limitations in 78 
data reporting and obtaining volume and usage data for individual surgeons. There were no 79 
limits on language of publication, number of patients, duration of follow-up or indication. 80 
Searches were performed in duplicate. All study authors were contacted to confirm the data 81 
extraction was correct and to determine caseload and usage of UKA. Figure 1. 82 
 83 
Outcome measures assessed 84 
For each study the number of UKA, number of revisions, reason for revision, and mean follow-85 
up were recorded in duplicate. In addition the caseload (UKA/surgeon/year) and usage 86 
(percentage of the surgeons primary knee practice that are UKA) of UKA was recorded and/or 87 
requested from authors. Quality of included studies was assessed using the Methodological 88 
Index for Non-Randomised Studies (MINORS) score[6]. 89 
 90 
 91 
 92 
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Caseload: UKA per surgeon per year 93 
Surgical caseload was divided based according to clinically plausible cut-points a priori, based 94 
on the system employed by the New Zealand Joint Registry[7]. Surgeons performing 95 
≤6UKA/year were considered very low-caseload, >6 and ≤12UKA/year low-caseload, >12 and 96 
≤24UKA/year medium-caseload and >24UKA/year high-caseload. 97 
 98 
Usage: UKA as a proportion of all primary knee arthroplasty 99 
Very low-usage was defined as surgeons who performed <10%UKA, low-usage ≥10% but 100 
<20%UKA, medium-usage ≥20% but <30%UKA and high-usage ≥30%. 101 
  102 
Combined caseload and usage 103 
To explore the interaction between caseload and usage four groups were created based on: 104 
low-caseload (≤12UKA/year) and high-usage (≥20%UKA), high-caseload (>12UKA/year) and 105 
high-usage (≥20%UKA), low-caseload (≤12UKA/year) and low-usage group (<20%UKA), and 106 
high-caseload (>12UKA/year) and low-usage group (<20%UKA).  107 
 108 
Statistical analysis 109 
The primary outcome was the all cause revision rate per 100 observed component years, which 110 
is otherwise known as the annual revision rate (%pa). This was calculated first by multiplying 111 
the number of knees by their mean follow up to determine the number of observed component 112 
years and then dividing the number of revisions observed by the number of component years 113 
and multiplying this by 100. As revisions for bearing dislocation occur early after the primary 114 
operation, and as such may not have a constant annual revision rate the absolute revision rate 115 
was calculated. Confidence intervals (CI) were calculated using the Clopper-Pearson, exact, 116 
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method[8]. As revision rates were expected to be low a Freeman-Tukey variance stabilising 117 
double arcsine transformation was used such that studies with zero rates would not be 118 
excluded[9]. Where a difference in the primary outcome was detected secondary outcomes 119 
were assessed: including the annual revision rate for lateral compartment disease progression, 120 
bearing dislocation, unexplained pain and aseptic loosening as these have been reported to be 121 
the predominant failure mechanisms of mobile-bearing UKA[4]. In addition the rates of other 122 
potential causes of revision, including revision for disease progression in the patello-femoral 123 
joint, polyethylene wear and tibial fracture were assessed.  124 
As revision rates follow a binomial distribution a meta-analysis of proportions was performed 125 
with summary annual revision rates pooled using a random effects model to minimize the effect 126 
of between-study heterogeneity[10, 11]. Statistical heterogeneity across studies was assessed 127 
using the I2 statistic[12]. 128 
Analysis was performed overall and based on those studies with long-term, mean 10-years or 129 
greater, outcomes with sub-group analysis based on caseload, usage and the interaction 130 
between caseload and usage as defined above. Analysis was conducted using Stata Version 13 131 
(Stata Corp, Texas, USA) with a p<0.05 considered statistically significant.  132 
M
A
N
U
S
C
R
IP
T
 
A
C
C
E
P
T
E
D
ACCEPTED MANUSCRIPT
8 
 
Results 133 
Searches identified a total of 3585 papers with an additional five-studies identified. Figure 1. 134 
After screening, the full-texts of 83 studies were retrieved and assessed with 37 excluded 135 
(Appendix 2) leaving 46 (12,520 knees 67,128 component years) meeting inclusion criteria. 136 
Table 1. The mean MINORS score of included studies was 12 (range 10-14). 137 
After contacting authors, data on the caseload was available for 37 studies (80%) and on usage 138 
for 34 studies (74%). Table 2. The smallest study, Palacios et al., had 24 observed component 139 
years and reported no failures and was found to skew the revision estimate towards zero[13]. 140 
Therefore, as generally recommended, this study was excluded from the quantitative 141 
analysis[13]. The analysis was repeated including this study and this did not change the 142 
interpretation of the results.     143 
The all cause revision rate was 1.21%pa (95%CI 0.97-1.47). Revision indications are outlined in 144 
Table 3. The revision rate for aseptic loosening was 0.19% pa (95%CI 0.09 to 0.32), for lateral 145 
compartment disease progression was 0.10% pa (95%CI 0.04 to 0.19), bearing dislocation 146 
0.10% pa (95%CI 0.05 to 0.17) and unexplained pain 0.05% pa (95%CI 0.01 to 0.11). Table 3. 147 
Out of the 12,520 knees there were 121 (0.97%) dislocations, 20 (0.16%) tibial plateau fracture, 148 
7 (0.06%) revisions for patella-femoral disease and 1 (0.01%) revision for polyethylene wear 149 
secondary to anterior impingement.  In series with long-term outcomes, mean follow-up 10-150 
years or greater, the all cause revision rate was 0.63%pa (95%CI 0.46-0.83). Table 3 & 4. 151 
 152 
Caseload: UKA per surgeon per year 153 
No difference in mean age (p=0.69), gender (p=0.71) or BMI (p=0.38) was seen between 154 
groups based on caseload.  155 
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The revision rate decreased as the caseload increased (p=0.02). Figure 2. The revision rate 156 
where surgeons performed: ≤6 UKA/year was 1.87%pa (95%CI 1.14-2.76), >6 but ≤12 157 
UKA/year was 1.25%pa (95%CI 0.77-1.83), >12 but under ≤24 UKA/year was 1.37%pa (95%CI 158 
0.93-1.89) and >24 UKA/year was 0.88%pa (95%CI 0.63-1.61). 159 
The revision rate for lateral compartment disease progression (p=0.005), unexplained pain 160 
(p=0.02) and aseptic loosening (p=0.003) decreased as caseload increased. No difference in 161 
annual revision rate (p=0.58) or absolute revision rate (p=0.17) for bearing dislocation was 162 
detected. Table 3. 163 
 164 
Usage: UKA as a proportion of all primary knee arthroplasty 165 
As usage of UKA increased the mean age increased (p=0.04). The mean age of patients in 166 
surgeons who performed UKA in <10% of cases was 63.4 years (SD4.2) increasing to 69.4 167 
years (SD4.3) in surgeons who implanted UKA in at ≥30% of cases. No difference in gender 168 
(p=0.27) or BMI (p=0.32) was seen.  169 
The revision rate decreased as usage of UKA increased (p<0.001). Figure 3. The revision rate 170 
in series where surgeons performed: <10% UKA was 1.89%pa (95%CI 1.15-2.80), ≥10% but 171 
<20% UKA was 1.48%pa (95%CI 0.91-2.18), ≥20% but <30% UKA was 1.25%pa (95%CI 1.07-172 
1.43) and ≥30% was 0.69%pa (95%CI 0.50-0.90).  173 
The revision rate for unexplained pain (p=0.02) and aseptic loosening (p=0.001) decreased as 174 
the usage of UKA increased. No difference in annual revision rate (p=0.94) or absolute revision 175 
rate (p=0.33) for bearing dislocation, or annual revision rate for lateral compartment disease 176 
progression (p=0.10) was seen. Table 3. 177 
 178 
 179 
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Combined caseload and usage 180 
No difference in mean age (p=0.84), gender (p=0.73) or BMI (p=0.19) was seen based on the 181 
combined caseload and usage of UKA. 182 
Significant differences in revision rate were seen between groups (p=0.004) with lower revision 183 
rates seen where there was higher UKA usage. The revision rate was 0.85%pa (95%CI 0.65-184 
1.08) in the low-caseload (≤12 UKA/year) and high-usage group (≥20% UKA) and 0.94%pa 185 
(95%CI 0.69-1.23) in the high-caseload (>12 UKA/year) and high-usage (≥20% UKA) group 186 
compared to 1.76%pa (95%CI 1.21-2.41) in the low-caseload (≤12 UKA/year) and low-usage 187 
group (<20% UKA) and 1.58%pa (95%CI 0.57-3.05) in the high-caseload (>12 UKA/year) and 188 
low-usage (<20% UKA) group. (With the Palacios et al. study included the revision rate in the 189 
low-caseload, high-usage group was 0.32%pa (95%CI 0.16-0.52)). Figure 4. 190 
Significant differences in the revision rate for lateral compartment disease progression 191 
(p=0.002), persistent pain (p=0.01) and aseptic loosening (p=0.001) were observed with the 192 
lowest revision rates seen in the high-caseload high usage series. No difference in annual 193 
revision rate (p=0.71) or absolute risk of revision (p=0.71) for bearing dislocation was detected. 194 
Table 3. 195 
 196 
  197 
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Discussion 198 
In published series of the cemented Phase 3 Oxford medial UKA (46studies, 12,520knees, 199 
67,128component years) the all cause revision rate was 1.21%pa (95%CI 0.97-1.47) falling to 200 
0.63%pa (95%CI 0.46-0.83) in series with a mean follow-up of 10-years or greater. Table 3. 201 
Aseptic loosening, progression of disease in the lateral compartment, bearing dislocation, and 202 
unexplained pain represented the predominant failure mechanisms with revisions for patella-203 
femoral joint disease (7cases) and polyethylene wear (1case) being exceedingly rare (<0.1%). 204 
Revision rates decreased with both increasing surgeon caseload (UKA/surgeon/year) and 205 
usage (percentage of primary knee arthroplasty that are UKA). It is well recognised, and 206 
expected, that revision rate should decrease with increasing caseload[4]. It is however 207 
counterintuitive that it should increase with usage. Kozinn & Scott (1989) described the ideal 208 
indications for a UKA, and subsequent studies suggested that these were satisfied in about 5% 209 
of knee replacements [14-16]. Kozinn and Scott also suggested that with broader indications, 210 
and thus increased usage, the revision rate would increase. This meta-analysis is the first 211 
review of clinical studies that has shown that this is not the case, supporting analysis of Registry 212 
data, and concluding that the revision rate decreases with increased usage, at least for mobile-213 
bearing UKA[5]. 214 
Usage was found to be more important than caseload: Usage was independent of caseload, 215 
with high-usage surgeons achieving equally good results regardless of their overall caseload, 216 
whereas caseload was not independent of usage. In low-usage surgeons the annual revision 217 
rate was almost double that of high-usage surgeons regardless of whether surgeons implanted 218 
a high number of UKA (high-caseload) or not (low-caseload).   The results of this study 219 
therefore suggest that to achieve optimum outcomes mobile-bearing UKA should be performed 220 
in a high proportion of a surgeon’s practice and suggests that surgeons who perform a low 221 
number of knee arthroplasties can still achieve good results provided that UKA is performed in 222 
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an adequate proportion. There were no studies available for high usage, very low-caseload 223 
surgeons (<6UKA/year), and as such we cannot recommend that surgeons do such small 224 
numbers, even if their usage is acceptable. 225 
As low-usage surgeons have a high revision rate, regardless of whether they have a low or 226 
high-caseload, the reasons for this are likely to be related to their indications for UKA, or 227 
possibly for revision of UKA, rather than their surgical technique. The primary indication for 228 
mobile-bearing UKA is antero-medial OA. This requires (a) medial bone-on-bone arthritis (b) 229 
functionally normal ACL (c) functionally normal MCL (d) full thickness lateral cartilage and (e) 230 
patellofemoral joint without lateral grooving and bone loss[17]. It has been demonstrated that 231 
around 50% of cases undergoing knee arthroplasty meet these criteria and that suitability for 232 
UKA can be identified pre-operatively using a structured radiographic assessment in 233 
combination with a radiographic Decision Aid[18]. It is striking that the lowest revision rate 234 
(0.69%pa) was achieved by those doing >30% of their knee replacements as UKA, who were 235 
presumably adhering closely to the recommended indications. 236 
Surgeons performing UKA in a low-proportion of cases and obtaining poor results are probably 237 
using inappropriate indications. Surgeons may be concerned that UKA will fail because of 238 
progression of disease in the retained compartments. Therefore they may only implant UKA if 239 
the retained compartments are pristine, which usually only occurs if there is early arthritis with 240 
partial thickness cartilage loss (PTCL) in the medial compartment. It is well known that patients 241 
with PTCL do not do well with TKA, so a mobile-bearing UKA may seem to be an ideal solution, 242 
as these patients tend to be young and active. However patients with PTCL also do badly with 243 
UKA and have worse outcomes compared to those with bone-on-bone anteromedial 244 
osteoarthritis[19, 20]. Whilst we can only speculate as to the reasons for failure, this study found 245 
that low-usage UKA surgeons operated on younger patients, and had revision rates for 246 
persistent pain that were ten-fold higher than high-usage surgeons, with both these features 247 
being associated with operating on knees with PTCL. Recent work has highlighted that around a 248 
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quarter of young patients (<60 years) undergoing arthroplasty are not suitable for UKA due to 249 
PTCL and it may be that low usage surgeons are performing UKA in these patients and 250 
achieving poor results as a consequence[21]. Further work is required to confirm this finding, as 251 
well as to clarify the results of registry studies which have reported higher failure rates of UKA in 252 
young patients, a finding not observed in cases series performed for bone-on-bone arthritis [22-253 
24]. 254 
A final consideration is that, the higher revision rate in low-usage surgeons may relate to their 255 
indications for revision. In this study low-usage surgeons had a higher revision rate due to 256 
aseptic loosening compared to high-usage surgeons. Aseptic loosening is typically identified 257 
radiographically by the presence of radiolucent lines around the prosthesis[25]. Following 258 
mobile-bearing UKA two types of tibial radiolucency are recognized: Physiological 259 
radiolucencies are common, occurring in two thirds of cases, and are non-progressive, narrow 260 
(<2mm) with well-defined sclerotic margins. They are not indicative or predictive of loosening 261 
nor are they a source of pain[26-28]. In contrast pathological radiolucencies are rare, 262 
progressive and poorly-defined and are suggestive of loosening or infection. It is likely that 263 
surgeons who have not learnt the correct indications for mobile-bearing UKA, and are therefore 264 
low-usage surgeons, have also not understood the relevance of these radiolucencies, and may 265 
be doing unnecessary revisions for physiological radiolucencies[29]. 266 
Whilst this study found a relationship between caseload and implant survival it was only the 267 
high-usage surgeons, >24 UKA/year, which appeared to have a lower failure rate. Figure 2. This 268 
result is different from previous studies which have reported a progressive decrease in failure 269 
rate with increasing caseload with revision rates in high-caseload series typically half to a 270 
quarter of that seen in low-caseload series[4, 30, 31]. One reason this relationship may not have 271 
been seen in this study is that in almost a quarter of the high-caseload studies included in this 272 
analysis were low-usage (4 of 17studies), which we found to be associated with higher failure 273 
rate[29, 32-34] . In cross-sectional studies, because of the relationship between caseload and 274 
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usage, we would expect the number of high-volume and low-usage UKA surgeons to be lower 275 
than seen in this series[4]. As such usage may be a confounding variable that has not been 276 
accounted for in previous reports. 277 
In series reporting the long-term outcomes (mean follow-up of 10-years or greater) of mobile-278 
bearing UKA the survival rate was 94% (95%CI 92–95). Table 3. This result is better than the 279 
10-year survival rate (88%, 95%CI 85-90) extrapolated from the annual revision rate for all 280 
series, which have, on average a shorter follow-up. One reason for this is that the annual 281 
revision rate tends to overestimate the long-term failure rate, particularly in studies with a high 282 
incidence of early failures and a short duration of follow-up. This is relevant to this study: firstly 283 
because with mobile-bearing UKA bearing dislocation tends to occur early, and secondly 284 
because many of the included studies represent the learning curve of the surgeons who may 285 
have more revisions during this period. However, the main reason why the revision rate of the 286 
10-year series is lower than all series combined is that all the ten-year series were from high-287 
usage surgeons, whereas the other series came from a mixture of low and high-usage surgeons 288 
with low-usage surgeons tending to get worse results. The main conclusion from this study is 289 
therefore that if surgeons want to use the mobile-bearing UKA they should use it for a high-290 
proportion of their knee replacements (≥20%). If they do this they should expect to achieve a 291 
similarly good survival as seen in studies with long-term outcomes (94% ten-year survival). 292 
There are limitations of this study: surgeons may over or understate their UKA caseload and 293 
usage, presenting a risk of recall bias. Due to limited information provided in published series it 294 
was not possible to evaluate functional outcomes which are critical in evaluating the optimum 295 
treatment. The study is based on published case series of UKA, which are open to publication 296 
bias. As the results of arthroplasty are expected to be good it may be easier to get poor results 297 
published early and these need only be based on small numbers of patients. In contrast it is 298 
difficult to get good results published, as these require large numbers of patients with long 299 
follow-up. Therefore a higher proportion of poor results may be published than good.  300 
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 301 
 302 
Conclusion 303 
To achieve optimum results with mobile-bearing UKA surgeons should use it for at least 20%, 304 
and ideally 50% of their knee replacements. To do this they should adhere to the recommended 305 
indications. This effect appears to be independent of the caseload of UKA performed meaning 306 
that optimum results can still achieved by relatively low-volume surgeons (>6 and <12/year). 307 
Surgeons with optimal usage should be able to achieve a 10-year survival of about 94%. 308 
  309 
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Table 1: Demographic Information of included studies 593 
Study Country Age Age range % male BMI BMI range MINORS Score 
Akan 2013[35] Turkey 64 42 - 84 17 29.8 19 – 42 11 
Amin 2006[36] UK 68 40 - 91 50 29.2 21 – 43 13 
Aslan 2007[37] Turkey 57 47 - 73 11 NS   11 
Bergeson 2013[38] USA 63 29 - 91 44 32.2 17 – 58 11 
Bhattacharya 2012[32] UK 69 50 - 83 50 NS   12 
Biau 2013[39] Canada 60 55 - 65 33 32.0 29 – 34 11 
Bottomley 2016[40] UK 67  49 NS   12 
Bozkurt 2013[41] Turkey 57  NS NS    11 
Burnett 2014[42] Canada 69 40 - 88 44 29.7 18 – 49 14 
Choy 2011[43] South Korea 65 44 - 82 10 NS    12 
Cinar 2010[44] Turkey 58 44 - 76 8 NS    11 
Clarius 2010[45] Germany 63 45 - 78 49 29.0 20 – 42 13 
Clark 2010[46] Australia 64 45 - 81 NS NS    11 
Clement 2012[47] UK 70  43 NS    12 
Cool 2006[48] Belgium 66 45 - 90 29 27.5   12 
Davidson 2013[49] UK 65 41 - 87 51 NS    10 
Dervin 2011[33] Canada 65 38 - 89 43 30.1 19 – 53 11 
Edmondson 2011[50] UK 67 57 - 86 NS NS    11 
Emerson 2016[51] USA 67 38 - 89 55 29.9 17 – 62 13 
Falcao 2014[52] Portugal 64 49 - 78 15 NS    11 
Faour-Martin 2013[53] Spain 59  29 27.1   12 
Heller 2009[54] Israel 63 45 - 80 32 NS    11 
Ingale 2013[55] UK 67 42 - 92 NS 29.3   12 
Ji 2014[56] South Korea 64 50 - 76 15 NS    11 
Keys 2013[57] UK 69 40 - 87 NS NS    13 
Kim KT 2015[58] South Korea 62 45 - 75 NS NS    12 
Kim SJ 2012[59] South Korea 67 49 - 79 19 NS    14 
Kort  2007[60, 61] The Netherlands 66 43 - 93 34 30.7   11 
Kuipers 2010[62] The Netherlands 63 39 - 85 32 NS    11 
Lim 2012[63] South Korea 69 48 - 82 NS NS    13 
Lisowski 2011[64] The Netherlands 73 43 - 91 NS 28.0 19 – 52 12 
Luscombe 2007[65] UK 63 41 - 79 NS 28.4   11 
Mallen 2014[66] Mexico 71 57 - 81 16 28.1 19 – 36 11 
Matharu 2012[67] UK 63 35 - 87 NS NS   11 
Munk 2011[34] Denmark 66  51 NS   11 
Nerhus 2012[68] Norway 65 51 - 80 41 NS   11 
Palacios 2007[69] Mexico NS 55 - 74 32 NS   10 
Pandit 2015[28] UK 66 32 - 88 48 NS   13 
Parmaksızoglu 2012[70] Turkey 67 56 - 75 26 NS   10 
Petersen 2013[71] Germany 71 59 - 79 NS NS   11 
Schroer 2013[29] USA 57 40 - 76 58 NS   12 
Smith 2012[72] UK 67  NS NS   11 
Song 2009[73] South Korea 66 57 - 82 7 NS   11 
Wagner-Kristensen 2013[74] Denmark 64 30 - 94 NS NS   12 
Whittaker 2010[75] Canada 63 49 - 87 NS 30.7 19.3 - 43.1 10 
Yoshida 2013[76] Japan 77 47 - 94 18 NS    13 
 594 
NS: Not stated. 595 
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Table 2: Details of included studies 597 
Study Number of 
knees  
Number of 
patients 
Mean follow-up 
(years) 
Follow-up range 
(years) 
Number of 
revisions 
Caseload 
(UKA/surgeon/year) 
Usage 
(% UKA) 
 
Akan 2013[35] 141 120 3.5 2.0 - 4.3 10 21 NS 
Amin 2006[36] 54 54 4.9 2.0 - 5.9 6 NS  NS 
Aslan 2007[37] 27 27 2.3 2.0 - 3.0 2 NS NS 
Bergeson 2013[38] 839 688 3.7 0.1 - 6.5 40 111 22 
Bhattacharya 2012[32] 49 44 5.6 2.0 - 9.9 1 15 5 
Biau 2013[39] 37 33 5.3 4.9 - 6.3 1 12 8 
Bottomley 2016[40] 1084 947 5.2  46 8 50 
Bozkurt 2013[41] 53 NS 1.2 0.5 - 3.3 1 NS 15 
Burnett 2014[42] 467 387 6.1 0.7 - 11.6 42 6 13 
Choy 2011[43] 188 166 6.7 4.7 - 8.6 17 48 34 
Cinar 2010[44] 41 40 1.6 0.8 - 3.5 1 NS 8 
Clarius 2010[45] 61 59 5.0 4.0 - 7.0 2 3 13 
Clark 2010[46] 398 398 3.6 1.0 - 8.5 15 11 20 
Clement 2012[47] 49 49 7.2  4 12 13 
Cool 2006[48] 50 49 3.7 2.6 - 5.0 3 NS  NS  
Davidson 2013[49] 699 699 4.2  39 54 27 
Dervin 2011[33] 545 545 3.8 2.3 - 7.4 32 18 17 
Edmondson 2011[50] 48 48 4.5 3.0 - 6.0 4 6 6 
Emerson 2016[51] 213 173 10.0 4.0 – 11.0 20 85 40 
Falcao 2014[52] 29 27 3.9 0.8 - 6.9 2 NS NS 
Faour-Martin 2013[53] 511 402 10.4  29 85 NS 
Heller 2009[54] 59 59 2.7  7 7 5 
Ingale 2013[55] 470 NS 3.9  29 5 9 
Ji 2014[56] 246 245 2.8 1.0 - 8.0 20 16 NS 
Keys 2013[57] 107 NS 11.5  6 24 31 
Kim KT 2015[58] 166 128 10.0  16 83 23 
Kim SJ 2012[59] 124 104 6.7 4.2 - 9.1 3 40 NS  
Kort 2007[60, 61] 200 175 4.0 2.0 - 7.0 19 8 4 
Kuipers 2010[62] 437 437 2.6 0.1 - 7.9 45 5 10 
Lim 2012[63] 400 320 5.2 1.0 - 10.0 14 44 30 
Lisowski 2011[64] 244 216 4.2 1.0 - 10.4 9 27 40 
Luscombe 2007[65] 78 68 2.0  4 23 22 
Mallen 2014[66] 30 25 6.1 1.1 - 11.5 3 3   
Matharu 2012[67] 459 392 4.4 0.5 - 11.2 23 8 18 
Munk 2011[34] 268 268 1.0  3 19 15 
Nerhus 2012[68] 99 96 2.0  6     
Palacios 2007[69] 24 22 1.0 0.7 - 3.0 0 6 33 
Pandit 2015[28] 1000 818 10.3 5.3 - 16.6 52 50 70 
Parmaksızoglu 2012[70] 38 38 2.0 1.5 - 2.7 0 NS NS 
Petersen 2013[71] 50 NS 5.0  3   NS 
Schroer 2013[29] 83 77 3.6 0.3 - 7.1 13 28 7 
Smith 2012[72] 230 NS 7.3  21 19 23 
Song 2009[73] 100 94 9.0  9 43 23 
Wagner-Kristensen 2013[74] 695 579 4.6 0.0 - 10.7 51 24 22 
Whittaker 2010 [75] 79 62 3.6 1.0 - 11.3 7 5 7 
Yoshida 2013[76] 1251 990 5.2 1.0 – 10.5 25 114 70 
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Table 3: Indications for revision 598 
 599 
 
All 
Cause 
Aseptic 
Loosening 
Lateral 
Progression 
Bearing 
Dislocation 
Unexplained 
Pain 
 
 
     
All series 1.21%pa 
(95%CI 0.97 to 1.47) 
0.19%pa 
(95%CI 0.09 to 0.32) 
0.10%pa 
(95%CI 0.04 to 0.19) 
0.10%pa 
(95%CI 0.05 to 0.17) 
0.05%pa 
(95%CI 0.01 to 0.11) 
 
     
Caseload 
     
≤6 UKA pa 1.87%pa 
(95%CI 1.14 to 2.76) 
0.36%pa 
(95%CI 0.15 to 0.64) 
0.59%pa 
(95%CI 0.35 to 0.87) 
0.08%pa 
(95%CI 0.01 to 0.19) 
0.19%pa 
(95%CI 0 to 0.60) 
>24 UKA pa 0.88%pa 
(95%CI 0.63 to 1.61) 
0.07%pa 
(95%CI 0.01 to 0.19) 
0.15%pa 
(95%CI 0.04 to 0.32) 
0.21%pa 
(95%CI 0.10 to 0.35) 
0.03%pa 
(95%CI 0 to 0.09) 
 
p-value 
 
 
0.02 
 
0.03 
 
0.005 
 
0.58 
 
0.02 
 
     
Usage 
     
<10%  1.89%pa 
(95%CI 1.15 to 2.80) 
0.65%pa 
(95%CI 0.17 to 1.36) 
0.19%pa 
(95%CI 0.05 to 0.39) 
0.04%pa 
(95%CI 0 to 0.18) 
0.22%pa 
(95%CI 0.02 to 0.57) 
≥30% 0.69%pa 
(95%CI 0.50 to 0.90) 
0.09%pa 
(95%CI 0.01 to 0.22) 
0.12%pa 
(95%CI 0.03 to 0.26) 
0.17%pa 
(95%CI 0.07 to 0.15) 
0.02%pa 
(95%CI 0.01 to 0.12) 
 
p-value 
 
 
<0.001 
 
0.001 
 
0.10 
 
0.94 
 
0.02 
 
     
Combined 
     
Low caseload, 
Low usage 
1.76%pa 
(95%CI 1.21 to 2.41) 
0.56%pa 
(95%CI 0.34 to 0.82) 
0.23%pa 
(95%CI 0.08 to 0.44) 
0.08%pa 
(95%CI 0.02 to 0.17) 
0.28%pa 
(95%CI 0.07 to 0.58) 
High caseload, 
Low usage 
1.58%pa 
(95%CI 0.57 to 3.05) 
0.62%pa 
(95%CI 0 to 2.17) 
0.58%pa 
(95%CI 0.31 to 0.91) 
0.06%pa 
(95%CI 0 to 0.23) 
0.09%pa 
(95%CI 0 to 0.27) 
Low caseload, 
High usage 
0.85%pa 
(95%CI 0.65 to 1.08) 
0.23%pa 
(95%CI 0.13 to 0.36) 
0.24 
(95%CI 0.14 to 0.38) 
0.12%pa 
(95%CI 0.05 to 0.22) 
0.06%pa 
(95%CI 0.01 to 0.13) 
High caseload, 
High usage 
0.94%pa 
(95%CI 0.69 to 1.23) 
0.16%pa 
(95%CI 0.05 to 0.31) 
0.12%pa 
(95%CI 0.04 to 0.25) 
0.18%pa 
(95%CI 0.08 to 0.30) 
0.04%pa 
(95%CI 0 to 0.11) 
 
p-value 
 
 
0.004 
 
0.001 
 
0.002 
 
0.71 
 
0.01 
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Table 4: Studies with mean follow-up of 10 years or greater 601 
Study Number of knees  Annual revision 
rate 
(%pa) 
Annual revision 
rate 95% CI 
(%pa) 
10y survival (%) 10y survival (%) 
95% CI 
Caseload 
(UKA/surgeon/year) 
Usage 
(% UKA) 
 
Emerson 2016[51] 213 0.94 0.57 – 1.45 90.6 85.5 – 94.3 85 40 
Faour-Martin 2013[53] 511 0.55 0.37 – 0.78 94.5 92.2 – 96.3 85 NS 
Keys 2013[57] 107 0.49 0.18 – 1.06 95.1 89.4 – 98.2 24 31 
Kim KT 2015[58] 166 0.96 0.55 – 1.56 90.4 84.4 – 94.5 83 23 
Pandit 2015[28] 1000 0.50 0.38 – 0.66 95.0 93.4 – 96.2 50 70 
OVERALL 
 0.63 0.46 – 0.83 93.7 91.7 – 95.4   
 602 
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Appendix 1 604 
1. Arthroplasty, Replacement, Knee/ 605 
2. Partial.ab 606 
3. unicompartmental.ab 607 
4. unicondylar.ab 608 
5. uni.ab 609 
6. UKA.ab 610 
7. UKR.ab 611 
8. UCA.ab 612 
9. UCR.ab 613 
10. PKA.ab 614 
11. PKR.ab 615 
12. PCA.ab 616 
13. Oxford.ab 617 
14. meniscal.ab 618 
15. mobile.ab 619 
16. OR/ 2-15 620 
17. 1 AND 16 621 
18. 17 (limited to humans) 622 
 623 
Database searched Date 
searched 
Number of results 
MEDLINE (OVID) & in Process 1946 to March 16, 
2016 
17/03/2016 1554 
EMBASE (OVID)  1996 to Week 11 2016 17/03/2016 975 
ISI Web of Science (SCI, SSCI, CPCI-S & CPCI-
SSH) searched to 20/01/15 
17/03/2016 1056 
Total 3585 
 624 
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Appendix 2: Excluded studies 626 
Study Country Reason excluded 
Aldinger 2004[77] Germany No survival data 
Catani 2012[78] Italy No survival data 
Chatellard 2013[79] France Not cemented Oxford Phase 3 
Daniilidis 2009[80] Germany No survival data 
Emerson 2002[81] USA Not cemented Oxford Phase 3 
Emerson 2008[82] USA Not cemented Oxford Phase 3 
Gleeson 2004[83] UK Non-consecutive patients 
Hooper 2015[84] New Zealand Not cemented Oxford Phase 3 
Jahromi 2004[85] Australia No survival data 
Kaczmarczyk 2003[86] Poland No survival data 
Kendrick 2015[87] UK No survival data 
Kubat 2011[88] Czech Republic No survival data 
Langdown 2005[89] UK Non-consecutive patients 
Li 2006[90] Australia Non-consecutive patients 
Liddle 2013[91] UK Not cemented Oxford Phase 3 
Ma 2013[92] China No survival data 
Mascitti 2005 [93] Italy No survival data 
Masri 2009[94] Canada Non-consecutive patients 
Mercier 2010[95] France Not cemented Oxford Phase 3 
Mullaji 2011[96] India No survival data 
Muller 2004[97] Germany Not cemented Oxford Phase 3 
Nassiri 2010[98] Ireland Non-consecutive patients 
Pandit 2013[99] UK Not cemented Oxford Phase 3 
Pandit 2015[100] UK Not cemented Oxford Phase 3 
Parratte 2012[101] France Not cemented Oxford Phase 3 
Pietschmann 
2014[102] 
Germany No survival data 
Rajasekhar 2004 [103] UK Not cemented Oxford Phase 3 
Shakespeare 
2012[104] 
UK No survival data 
Skowronski 2005[105] Poland Not cemented Oxford Phase 3 
Streit 2015[106] Germany Non-consecutive patients 
Sun 2012[107] China Non-consecutive patients 
Tang 2012[108] China No survival data 
Tuncay 2015[109] Turkey Non-consecutive patients 
Verdonk 2005[110] Belgium Not cemented Oxford Phase 3 
Volpin 2006 Israel No survival data 
Vorlat 2006[111] Belgium Not cemented Oxford Phase 3 
White 2012[112] UK Not cemented Oxford Phase 3 
Zermatten 2012[113] Switzerland Not cemented Oxford Phase 3 
 627 
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Choy (2011)
Lim (2012)
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Song (2009)
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Keys (2013)
Pandit (2015)
Akan (2013)
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Overall  (I^2 = 84.49%, p = 0.00);
Matharu (2012)
Kort a & b (2007)
4. >=30% UKA
Emerson (2016)
Subtotal  (I^2 = 72.11%, p = 0.00)
Bozkurt (2013)
Yoshida (2013)
Lim (2012)
Clement (2012)
Song (2009)
Choy (2011)
Burnett (2014)
3. >=20% & <30% UKA
Cinar (2010)
2. >=10% & <20% UKA
Whittaker (2010)
Biau (2013)
Bhattacharya (2012)
Bergeson (2013)
Ingale (2013)
Keys (2013)
Kuipers (2010)
Subtotal  (I^2 = 77.09%, p = 0.00)
Clarius (2010)
Pandit (2015)
Smith (2012)
Luscombe (2007)
Study
Subtotal  (I^2 = 61.19%, p = 0.01)
Wagner−Kristensen (2013)
Kim KT (2015)
Schroer (2013)
Davidson (2013)
Lisowski (2011)
Munk (2011)
Heller (2009)
1. <10% UKA
Bottomley (2016)
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Edmondson (2011)
Dervin (2011)
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Pandit (2015)
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Study
Subtotal  (I^2 = 84.18%, p = 0.00)
Keys (2013)
Clement (2012)
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Burnett (2014)
Bhattacharya (2012)
Bergeson (2013)
2. High caseload & low usage
4. High caseload & high usage
Clarius (2010)
Munk (2011)
Davidson (2013)
Kim KT (2015)
Smith (2012)
Song (2009)
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Matharu (2012)
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Choy (2011)
Bottomley (2016)
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Figure Legends 
Figure 1 - PRISMA flow diagram of included studies 
Figure 2 - Outcomes of UKA by surgical caseload (UKA per surgeon per year) 
Figure 3 - Outcomes of UKA by surgical usage (percentage of primary knee arthroplasty that are 
UKA) 
Figure 4 - Outcomes of UKA by combined surgical caseload and usage 
 
